Press release Oncology Venture & Alpha Blue Ocean mutually terminates agreement with EHGO as part of final financing

NEXT STORY
ASLAN Pharmaceuticals to Present at 9th Annual SVB Leerink Global Healthcare Conference
PREV STORY
Novartis announces FDA and EMA filing acceptance of ofatumumab, a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Two Performance Studies on Idylla(TM) MSI Biomarkers Selected for Publication at ASCO Conference

PRESS RELEASE: 17 May 2018, 07:00 CEST Two Performance Studies on Idylla(TM) MSI Biomarkers Selected ...

author_avatar
NASDAQ Market News

Inovio Signs Collaborative Research Agreements With Wistar Institute for DNA-based Immunotherapies and Vaccines

New Agreement Follows Dr. David B. Weiner’s Move to Wistar from the University of ...

author_avatar
NASDAQ Market News